Jon Hamilton

Some days, though, she has trouble finding her way around her own house. On one of those days, she began asking Ken to move her to a care home. So Ken found one she liked.

Sue is still at home, but Ken says at some point she'll need more care than he can provide. Myra Solano-Garcia is 66 and has been living with Alzheimer's for more than a decade.

Sue is still at home, but Ken says at some point she'll need more care than he can provide. Myra Solano-Garcia is 66 and has been living with Alzheimer's for more than a decade.

Sue is still at home, but Ken says at some point she'll need more care than he can provide. Myra Solano-Garcia is 66 and has been living with Alzheimer's for more than a decade.

But there's still a lot that Solana Garcia can do around her home in Upland, California.

But there's still a lot that Solana Garcia can do around her home in Upland, California.

But there's still a lot that Solana Garcia can do around her home in Upland, California.

And she can take part in an activity that has played a central role in her life. One reason may be the drug known generically as Denanamab and marketed under the name Casanla. It's one of two new drugs that can clear the brain of sticky amyloid plaques, one of the hallmarks of Alzheimer's. Solano Garcia grew up in New Jersey as part of a Cuban-American family with lots of singers.

And she can take part in an activity that has played a central role in her life. One reason may be the drug known generically as Denanamab and marketed under the name Casanla. It's one of two new drugs that can clear the brain of sticky amyloid plaques, one of the hallmarks of Alzheimer's. Solano Garcia grew up in New Jersey as part of a Cuban-American family with lots of singers.

And she can take part in an activity that has played a central role in her life. One reason may be the drug known generically as Denanamab and marketed under the name Casanla. It's one of two new drugs that can clear the brain of sticky amyloid plaques, one of the hallmarks of Alzheimer's. Solano Garcia grew up in New Jersey as part of a Cuban-American family with lots of singers.

Later, she ran fundraising campaigns for colleges and universities and moved to California. It was in her early 50s that Solana Garcia began noticing problems with her memory. The turning point came during COVID when she started a new job.

Later, she ran fundraising campaigns for colleges and universities and moved to California. It was in her early 50s that Solana Garcia began noticing problems with her memory. The turning point came during COVID when she started a new job.

Later, she ran fundraising campaigns for colleges and universities and moved to California. It was in her early 50s that Solana Garcia began noticing problems with her memory. The turning point came during COVID when she started a new job.

So she went to a neuropsychiatrist.

So she went to a neuropsychiatrist.

So she went to a neuropsychiatrist.

The doctor also referred her to the University of Southern California, which was part of a large study of Dananamab.

The doctor also referred her to the University of Southern California, which was part of a large study of Dananamab.

The doctor also referred her to the University of Southern California, which was part of a large study of Dananamab.

Solano-Garcia began going in for monthly infusions, which she didn't mind, and mental tests, which she found frustrating.